Skip to main content
OpenTrials

Clinical trial condition

Hypertrophy

Explore clinical trials studying Hypertrophy. Study availability and eligibility vary by location and protocol.

165 public trials 29 recruiting studies
Refine in advanced search Browse all conditions

Hypertrophy trial results

Completed

SGLT2 Inhibition in Hemodialysis

NCT05179668

Conditions
Cardiomegaly, Cardiovascular Diseases, Chronic Disease, +25 more
Locations
  • Dialyseinstitut Dr. Waller Feldbach, Austria
  • Dialyseinstitut Gießauf GmbH Graz, Austria
  • Klinik Landstraße Vienna, Austria
  • Medical University of Vienna Vienna, Austria
View Trial Details
Completed

PREDIGA 2: Spanish Acronym of "Educational and Diagnostic Project for Gaucher and ASMD"

NCT05641103

Conditions
ASMD, Acid Sphingomyelinase Deficiency, Brain Diseases, +25 more
Locations
  • Hospital General Universitario de Alicante Alicante, Spain
  • Hospital de Poniente El Ejido, Almería, Spain
  • Hospital Universitario de Badajoz Badajoz, Spain
  • Hospital Vall d'Hebron Barcelona, Spain
View all 14 locations
View Trial Details
Completed

A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis

NCT03222609

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • UAB Comprehensive Cancer Cente /ID# 165464 Birmingham, Alabama, United States
  • TOI Clinical Research /ID# 222546 Cerritos, California, United States
  • City of Hope /ID# 221395 Duarte, California, United States
  • Moores Cancer Center at UC San Diego /ID# 164084 La Jolla, California, United States
View all 91 locations
View Trial Details
Completed

A Non-Interventional National Study in Pediatric Patients With Unexplained Enlarged Spleen

NCT04845958

Conditions
Acid Sphingomyelinase Deficiency, Brain Diseases, Brain Diseases, Metabolic, +25 more
Locations
  • Investigational Site Number 2500036 Amiens, France
  • Investigational Site Number 2500014 Angers, France
  • Investigational Site Number 2500034 Argenteuil, France
  • Investigational Site Number 2500039 Bayonne, France
View all 40 locations
View Trial Details
Completed

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

NCT03499808

Conditions
Amorphous, Eosinophilic, and Acellular Deposit, Amyloidosis, Blood Coagulation Disorders, +40 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 345 locations
View Trial Details

Related conditions